E-ISSN: 3048-5681 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
International Journal of Vaccines [3048-5681(e)] is a peer-reviewed open-access journal launched in 2024 that focuses on the International Journal of Vaccines was on all facets of vaccine research. It explains the complex characteristics of atypical disease symptoms followed by …
ijv maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Amit Awasthi, Senior Professor
Translational Health Science & Technology Institute, Haryana, India,
Email :
Institutional Profile Link: https://thsti.res.in/en/faculty-profile/Amit-Awasthi
Journal: International Journal of Vaccines
Vaccine development and manufacturing have become increasingly complex due to the emergence of diverse vaccine platforms, stringent regulatory expectations, and global demand for safe and effective immunization
Over the past decade (2015-2025), viral evolution has profoundly reshaped the global health landscape, challenging healthcare systems, diagnostic tools, therapeutic strategies, and vaccine efficacy.
India's substantial research on epidemiology, virology, and public health measures has helped the world understand viral infections better.
The widespread availability of human papillomavirus (HPV) vaccines in some countries throughout the last ten years has demonstrated encouraging outcomes in reducing HPV infection and associated conditions including warts and precancerous lesions.
Rubella is a mild illness; however, it becomes severely threatening when associated
with congenital rubella syndrome (CRS) for women of childbearing age.
Messenger RNA (mRNA) technology has brought a major change in modern medicine, especially after its
successful use in COVID-19 vaccines.
